Talk to Us
Talk to Us

Consulting for Procurers

De-Risk Your R&D and Defend Your Innovation.

Compliance is your license to innovate. We ensure lawful access, structured benefit-sharing, and full ABS alignment from research to commercialization.

Talk to Us

Does the Nagoya Protocol Apply to Your Pipeline?

Do you use genetic or biological resources for research, product development, or commercialisation?

Do you source biological materials plants, microbes, marine organisms, extracts for commercial use?

Do you file IP (patents, plant varieties, formulations) based on such research?

Do you import biological raw materials or export finished products derived from them?

  • If yes to any, your activities fall under the Nagoya Protocol regulations.

End-to-End Execution, Not Just Advice.

We don’t just advise; we execute. Our end-to-end service covers every aspect of Access and Benefit-Sharing (ABS) to secure your operations.

ABS Due Diligence

Rigorous assessment of supplier countries and genetic resource provenance.

PIC Strategy & Acquisition

Obtaining Prior Informed Consent (PIC) from competent national authorities.

ABS-IP Alignment

Ensuring patent filings disclose origin as required by evolving patent laws.

Documentation & IRCC

Securing the Internationally Recognized Certificate of Compliance (IRCC).

Regulatory Clarity Before Market Expansion.

Country-wise approved product listings.

Import/export regulatory requirements.

Restricted and banned ingredient tracker.

Certification requirements across jurisdictions.

Expand with confidence. Avoid costly reformulations. We provide structured intelligence across jurisdictions governed by the Food Safety and Standards Authority of India (FSSAI), U.S. Food and Drug Administration (USFDA), U.S. Department of Agriculture (USDA), and the European Food Safety Authority (EFSA).

Defend Your Innovation. Increase Enterprise Value.

IP filings increasingly require ABS disclosure. IP built on compliant access becomes defensible capital.

Freedom-to-Operate (FTO) Analysis.

Patentability & White-Space Strategy.

ABS-Aligned IP
Structuring.
Portfolio Valuation
Strategy

Intelligence That Drives Growth.

In life science business, growth belongs to the informed. Where to compete. How to win. When to enter.

Label Claim Expansion
To Identify label claim expansion opportunity.

Therapeutic Segment Mapping
Country-wise therapeutic segment mapping

I am tab 1 content. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Granular Competitor Tracking
Granular-level competitor tracking .

I am tab 1 content. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Use Case Forecasting
Forecast for the use case/disease/condition.

I am tab 1 content. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Agency Approval Pathways
Agencies you will deal with and specified approval pathways.

I am tab 1 content. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Request a Custom Market Intelligence Brief.

Let’s assess your biodiversity exposure, market position, and innovation strategy.

Talk to an Expert

Join the Ecosystem

Partner with us to build nature-positive supply chains through responsible genetic resource use, driving biodiversity conservation and enabling compliant, transparent sourcing.